MIT Team Wins Up to $38M for Sepsis Patch

The four-year PYTHIA project aims to build a noninvasive wearable sensor that monitors heart failure and sepsis biomarkers.

Updated on Nov. 4, 2026 in Heart Disease

MIT Team Wins Up to $38M for Sepsis Patch

Live Poll

Should the federal government fund more research into wearable health monitors?

MIT leads a team awarded up to $38 million from the U.S. Advanced Research Projects Agency for Health to develop a wearable chip-based patch. The noninvasive device monitors biomarkers in interstitial fluid and is powered by heat from the patient's body.

Why it matters

Heart disease is the leading cause of death in the U.S., and sepsis kills at least 350,000 U.S. adults each year. Earlier detection of these conditions could improve diagnosis and treatment across the country.

The project is funded by a maximum of $38 million over four years from ARPA-H, a federal research agency. Clinical efficacy has not been reported, and the device must still advance through pre-clinical and clinical trials.

The players

Massachusetts Institute of Technology (MIT)

A private research university in Cambridge, Massachusetts, known for its engineering and science programs, which leads the PYTHIA project.

Ahmad Bahai

A professor of the practice in MIT's Department of Electrical Engineering and Computer Science who serves as principal investigator on the project.

Advanced Research Projects Agency for Health (ARPA-H)

A U.S. federal research agency created to fund high-risk health technology projects, which is providing up to $38 million for the PYTHIA project.

The details

Led by principal investigator Ahmad Bahai, a professor of the practice in MIT's Department of Electrical Engineering and Computer Science, the PYTHIA project grew out of the MIT Program for Health Sciences and Semiconductors. The patch uses a chemical reaction to bind chemicals to biomarker molecules, making them easier to identify, and on-chip AI models will translate raw data into information for clinicians.

Four-year project period funded by ARPA-H
Bahai co-founded the HS+S program three years ago upon joining MIT

Big Picture

The award follows ARPA-H's model of funding high-risk health technology through federal research grants. It positions wearable biomarker monitoring as a potential tool for earlier detection of sepsis and heart failure.

If the PYTHIA device reaches market, patients recovering from hospital stays could be monitored outside clinical settings. The device is still in development and is not yet available to patients.

The takeaway

Continuous, noninvasive biomarker monitoring could shift heart failure and sepsis care from reactive treatment toward earlier intervention. Readers should watch for clinical trial results before expecting the technology in routine care.